Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze

Pharmacology Biochemistry and Behavior

Volumn 73, Issue 4, 2002, Pages 963-969

  Bertoglio, L J ^a   Carobrez, A P ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Anxiety; Elevated plus maze; Ethanol; One trial tolerance; Phenobarbital; Prior test experience; Rat

Indexed keywords

ALCOHOL; PHENOBARBITAL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXPERIENCE; EXPLORATORY BEHAVIOR; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ETHANOL; EXPLORATORY BEHAVIOR; MALE; MAZE LEARNING; PHENOBARBITAL; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0036828290     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(02)00958-9     Document Type: Article

References (47)

1. Bennett D.A., Amrick C.L. 2-Amino-7-phosphonoheptanoic acid (AP7) produces discriminative stimuli and anticonflict effects similar to diazepam. Life Sci. 39(25):1986;2455-2461.
2. Bertoglio L.J., Carobrez A.P. Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety. Behav. Brain Res. 108(2):2000;197-203.
3. Bertoglio L.J., Carobrez A.P. Behavioral profile of rats submitted to session 1-session 2 in the elevated plus-maze during diurnal/nocturnal phases and under different illumination conditions. Behav. Brain Res. 132(2):2002;135-143.
4. Bertoglio L.J., Carobrez A.P. Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze. Pharmacol. Biochem. Behav. 72:2002;449-455.
5. Boerngen-Lacerda R., Souza-Formigoni M.L. Does the increase in locomotion induced by ethanol indicate its stimulant or anxiolytic properties? Pharmacol. Biochem. Behav. 67(2):2000;225-232.
6. Chacur C., Raymond R., Hipolide D.C., Giugliano E.B., Leite J.R., Nobrega J.N. Immediate increase in benzodiazepine binding in rat brain after a single brief experience in the plus maze: a paradoxical effect. Neurosci. Lett. 269(1):1999;29-32.
7. Chandler L.J., Harris R.A., Crews F.T. Ethanol tolerance and synaptic plasticity. Trends Pharmacol. Sci. 19(12):1998;491-495.
8. Cole J.C., Rodgers R.J. An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav. Pharmacol. 4(6):1993;573-580.
9. Cole J.C., Littleton J.M., Little H.J. Effects of repeated ethanol administration in the plus maze; a simple model for conditioned abstinence behaviour. Psychopharmacology. 142(3):1999;270-279.
10. Crews F.T., Morrow A.L., Criswell H., Breese G. Effects of ethanol on ion channels. Int. Rev. Neurobiol. 39:1996;283-367.
11. Criswell H.E., Breese G.R. A conflict procedure not requiring deprivation: evidence that chronic ethanol treatment induces tolerance to the anticonflict action of ethanol and chlordiazepoxide. Alcohol., Clin. Exp. Res. 13(5):1989;680-685.
12. Criswell H.E., Overstreet D.H., Rezvani A.H., Johnson K.B., Simson P.E., Knapp D.J., Moy S.S., Breese G.R. Effects of ethanol, MK-801, and chlordiazepoxide on locomotor activity in different rat lines: dissociation of locomotor stimulation from ethanol preference. Alcohol., Clin. Exp. Res. 18(4):1994;917-923.
13. Cruz A.P., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49(1):1994;171-176.
14. Dawson G.R., Crawford S.P., Stanhope K.J., Iversen S.D., Tricklebank M.D. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure. Psychopharmacology. 113(3-4):1994;570-572.
15. Espejo E.F. Effects of weekly or daily exposure to the elevated plus-maze in male mice. Behav. Brain Res. 87(2):1997;233-238.
16. Fernandes C., File S.E. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol. Biochem. Behav. 54(1):1996;31-40.
17. Ferreira V.M., Takahashi R.N., Morato G.S. Dexamethasone reverses the ethanol-induced anxiolytic effect in rats. Pharmacol. Biochem. Behav. 66(3):2000;585-590.
18. File S.E. The interplay of learning and anxiety in the elevated plus-maze. Behav. Brain Res. 58(1-2):1993;199-202.
19. File S.E., Zangrossi H. "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology. 110(1-2):1993;240-244.
20. File S.E., Mabbutt P.S., Hitchcott P.K. Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology. 102(1):1990;98-101.
21. File S.E., Zangrossi H., Viana M., Graeff F.G. Trial 2 in the elevated plus-maze: a different form of fear? Psychopharmacology. 111(4):1993;491-494.
22. File S.E., Gonzalez L.E., Gallant R. Role of the basolateral nucleus of the amygdala in the formation of a phobia. Neuropsychopharmacology. 19(5):1998;397-405.
23. File S.E., Gonzalez L.E., Gallant R. Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on Trial 2 in the elevated plus-maze test of anxiety. Neuropsychopharmacology. 21(2):1999;312-320.
24. Gonzalez L.E., File S.E. A five-minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J. Neurosci. 15;17(4):1997;1505-1511.
25. Griebel G., Rodgers R.J., Perrault G., Sanger D.J. Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test. Pharmacol. Biochem. Behav. 57(4):1997;817-827.
26. Guimaraes F.S., Carobrez A.P., De Aguiar J.C., Graeff F.G. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology. 103(1):1991;91-94.
27. Hale R.L., Johnston A.L., Becker H.C. Indomethacin does not antagonize the anxiolytic action of ethanol in the elevated plus-maze. Psychopharmacology. 101(2):1990;203-207.
28. Hascoet M., Bourin M., Couetoux du Tertre A. Influence of prior experience on mice behavior using the four-plate test. Pharmacol. Biochem. Behav. 58(4):1997;1131-1138.
29. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54(1):1996;21-30.
30. Holmes A., Rodgers R.J. Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state? Pharmacol. Biochem. Behav. 60(2):1998;473-488.
31. Holmes A., Rodgers R.J. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci. Biobehav. Rev. 23(7):1999;971-980.
32. Holmes A., Iles J.P., Mayell S.J., Rodgers R.J. Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test. Behav. Brain Res. 122(2):2001;159-167.
33. Johnston A.L., File S.E. Sodium phenobarbitone reverses the anxiogenic effects of compounds acting at three different central sites. Neuropharmacology. 28(1):1989;83-88.
34. Koob G.F., Wall T.L., Schafer J. Rapid induction of tolerance to the antipunishment effects of ethanol. Alcohol. 4(6):1987;481-484.
35. LaBuda C.J., Fuchs P.N. Catecholamine depletion by reserpine blocks the anxiolytic actions of ethanol in the rat. Alcohol. 26(1):2002;55-59.
36. LaBuda C.J., Hale R.L. Anxiety in mice following acute aspartame and ethanol exposure. Alcohol. 20(1):2000;69-74.
37. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92(2):1987;180-185.
38. McGregor I.S., Dielenberg R.A. Differential anxiolytic efficacy of a benzodiazepine on first versus second exposure to a predatory odor in rats. Psychopharmacology. 147(2):1999;174-181.
39. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14(3):1985;149-167.
40. Pereira J.K., Vieira R.J., Konishi C.T., Ribeiro R.A., Frussa-Filho R. The phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze is abolished by the introduction of a motivational conflict situation. Life Sci. 65(10):1999;101-107.
41. Prunell M., Escorihuela R.M., Fernandez-Teruel A., Nunez J.F., Tobena A. Anxiolytic profiles of alprazolam and ethanol in the elevated plus-maze test and the early acquisition of shuttlebox avoidance. Pharmacol. Res. 29(1):1994;37-46.
42. Rodgers R.J. Animal models of 'anxiety': where next? Behav. Pharmacol. 8(6-7):1997;477-496.
43. Rodgers R.J., Shepherd J.K. Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology. 113(2):1993;237-242.
44. Rodgers R.J., Lee C., Shepherd J.K. Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology. 106(1):1992;102-110.
45. Rodgers R.J., Johnson N.J., Cole J.C., Dewar C.V., Kidd G.R., Kimpson P.H. Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade. Pharmacol. Biochem. Behav. 54(1):1996;41-50.
46. Treit D., Menard J., Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Biochem. Behav. 44:1993;463-469.
47. White A.M., Roberts D.C., Best P.J. Context-specific tolerance to the ataxic effects of alcohol. Pharmacol. Biochem. Behav. 72:2002;107-110.